New mammogram machine aims to spot breast cancer earlier
NCT ID NCT07067788
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a new mammogram machine (Siemens MAMMOMAT B.brilliant) to a standard one (Siemens MAMMOMAT Revelation) to see if it provides clearer images of breast calcifications, which can be a sign of cancer. About 100 women with suspicious calcifications will get both scans. The goal is to improve early detection without any new treatments or risks beyond a standard mammogram.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Mammogram machine (Siemens MAMMOMAT B.brilliant)
What this could lead to
If successful, this could lead to more accurate breast cancer screening by improving the detection of suspicious calcifications.
What could go wrong
This is a small, early-stage observational study (100 participants) comparing two FDA-approved machines. It does not test a new treatment, and results may not change current screening practices.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER SCREENING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pennsylvania Hospital, Center for Breast Imaging
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••